Trilogy Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $540K | Sell |
1,332
-176
| -12% | -$71.4K | 0.03% | 227 |
|
2025
Q1 | $750K | Buy |
1,508
+6
| +0.4% | +$2.99K | 0.04% | 187 |
|
2024
Q4 | $781K | Sell |
1,502
-2
| -0.1% | -$1.04K | 0.04% | 188 |
|
2024
Q3 | $930K | Sell |
1,504
-44
| -3% | -$27.2K | 0.05% | 176 |
|
2024
Q2 | $856K | Buy |
1,548
+1,046
| +208% | +$578K | 0.05% | 175 |
|
2024
Q1 | $292K | Buy |
502
+57
| +13% | +$33.1K | 0.02% | 256 |
|
2023
Q4 | $236K | Sell |
445
-15
| -3% | -$7.96K | 0.01% | 240 |
|
2023
Q3 | $233K | Buy |
460
+16
| +4% | +$8.1K | 0.02% | 242 |
|
2023
Q2 | $250K | Buy |
444
+24
| +6% | +$13.5K | 0.02% | 251 |
|
2023
Q1 | $242K | Sell |
420
-25
| -6% | -$14.4K | 0.02% | 231 |
|
2022
Q4 | $245K | Buy |
445
+44
| +11% | +$24.2K | 0.02% | 232 |
|
2022
Q3 | $203K | Buy |
+401
| New | +$203K | 0.02% | 174 |
|
2018
Q4 | – | Sell |
-16
| Closed | -$4K | – | 519 |
|
2018
Q3 | $4K | Hold |
16
| – | – | ﹤0.01% | 437 |
|
2018
Q2 | $3K | Hold |
16
| – | – | ﹤0.01% | 427 |
|
2018
Q1 | $3K | Buy |
+16
| New | +$3K | ﹤0.01% | 360 |
|